Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Abeona Therapeutics Inc. and Advises Investors with Losses to Contact the Firm

ABEO

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Abeona Therapeutics Inc. and Advises Investors with Losses to Contact the Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating Abeona Therapeutics Inc. (“Abeona” or the “Company”) (Nasdaq: ABEO) concerning possible violations of federal securities laws.

If you purchased or otherwise acquired Abeona shares and would like more information regarding the investigation, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

Mako Research published a report on SeekingAlpha.com finding that “ABEO science is demonstrably unviable with numerous irrefutable flaws that will lead to failure.” According to the report, Steven H. Rouhandeh, the Company’s Executive Chairman and Principal Executive Officer, was once a managing director at D. Blech & Co., a brokerage firm that was the subject of SEC investigations during the 1990s and was subject to a securities class action suit that resulted in a $15 million investor settlement due to allegations that the firm manipulated the price of some biotech stocks through transactions that artificially inflated the market price of the stocks to keep the firm’s interest in these stocks afloat. When this information was revealed to the public, the value of Abeona fell, causing investors severe harm.

If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at info@goldberglawpc.com.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Goldberg Law PC, Los Angeles
Michael Goldberg, Esq., 800-977-7401
Brian Schall, Esq., 800-977-7401
info@goldberglawpc.com
http://www.Goldberglawpc.com

Tags:


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today